First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

Oncology Today with Dr Neil Love

EpisodeApr 957m

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

Oncology Today with Dr Neil Love

EpisodeApr 957m

Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here.

Top comments

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

www.researchtopractice.com

Switch to the Fountain App

Open in Fountain